Syracuse VA Medical Center
Syracuse, New York, 13210, United States
Location contact
Katherine A Buckheit, PhD
CONTACT
315-425-4400 ext. 56742
Katherine A Buckheit, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07414589
The goal of this study is to develop and test a brief behavioral treatment for women Veterans with alcohol use in primary care. The study involves a development phase, an open trial phase, and a pilot randomized controlled trial. The main questions it aims to answer are:
* Is the treatment feasible and acceptable to women Veteran primary care patients? * Can the treatment help reduce alcohol use, alcohol-related problems, and improve quality of life? Researchers will compare the new treatment to usual treatment that primary care patients would normally receive. Participants will be asked to participate in either the new behavioral treatment or usual primary care treatment and attend 3 appointments to answer questions about their alcohol use, quality of life, other mental health symptoms, and what they thought of their behavioral treatment.
Trial opening soon.
Get Notified18 year and older
Female
Interventional
Not applicable
Syracuse, New York, 13210, United States
Katherine A Buckheit, PhD
CONTACT
315-425-4400 ext. 56742
Katherine A Buckheit, PhD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention consists of 4-6 30-minute behavioral health appointments with a behavioral health provider in an integrated primary care setting. It includes 4 core alcohol-focused appointments focused on providing information and skills to manage unhealthy alcohol use that have been adapted from existing evidence-based treatments in integrated primary care and specialty care. Participants may elect to attend up to 2 additional optional appointments focused on supplemental strategies to manage alcohol use or to address co-occurring mental and behavioral health concerns, including mood, trauma, sleep, and pain.
Primary care usual care consists of universal annual alcohol screening; those who are identified as at-risk receive a brief advice intervention from their primary care provider and may be offered an integrated primary care referral. The brief advice intervention is standardized and triggered automatically by a positive screen. Integrated primary care consists of brief assessment and intervention with licensed, independent behavioral health providers. Patients may decline integrated primary care referrals, complete several appointments, and/or be referred to specialty treatment
Time frame: From baseline to 6 months post-treatment
Quality of life will be assessed by the abbreviated World Health Organization Quality of Life Assessment (WHOQOL-BREF), a 26-item self-report measure of QoL in the past 2 weeks in 4 areas (social, physical, psychological, and environment) on a 1-5 scale.
Time frame: From baseline to 6 months post-treatment
Alcohol problems will be assessed by the Short Inventory of Problems-Revised (SIP-R)147, a 17-item self-report measure of frequency of alcohol problems on a 0-3 scale.
Time frame: Baseline to 6 months post-treatment
Alcohol-specific functional impairment will be assessed by the Addiction Severity Index - Lite, a semi-structured interview developed among Veterans in substance use treatment that assesses alcohol and drug use and problems and 5 areas of functioning: medical, legal, psychiatric, employment, and family/social
Time frame: For the duration of the intervention period, 8-12 weeks post-baseline.
Length of sessions in the experimental condition will be measured to test if the average is within guidelines for integrated primary care treatment (30 minutes maximum).
Time frame: For the duration of the intervention period, 8-12 weeks post-baseline.
An independent rater will listen to session tapes and record if each essential element was delivered on a checklist.
Time frame: After completing the behavioral health treatment, 8-12 weeks post-baseline.
Patient acceptability will be assessed with the Client Satisfaction Questionnaire (CSQ), an 8-item self-report measure. Acceptability ratings of at least "moderate" on the majority (5/8) of items on the CSQ will be considered acceptable.
Time frame: Baseline to 6 months post-treatment
Alcohol use will be assessed with the Timeline Followback (TLFB), a calendar-based measure that records standard drinks consumed each day in the past month to yield percent of drinking days, average drinks per drinking day, percent of heavy drinking (i.e., ≥4 drinks/occasion) days, and a variable indicating if alcohol use is above NIAAA-recommendations.
Contact information is provided by the study sponsor or research team.
Syracuse VA Medical Center
Fed
A Brief, Integrated Intervention for Women Veterans With Unhealthy Alcohol Use in Primary Care
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07731932
Acquired Immunodeficiency Syndrome, Alcohol Drinking
Mbarara, Uganda
View Trial DetailsNCT07515586
Alcohol Misuse, Behavior
Atlanta, Georgia, United States
View Trial DetailsNCT07683702
Alcohol Misuse, Alcohol Prevention
View Trial DetailsNCT07661563
Alcohol Misuse, Disease Attributes
Palo Alto, California, United States
View Trial Details